Therapeutic Plasma Exchange as a Treatment for Autoimmune Neurological Disease

Table 1

Demographic and TPE characteristics.

Characteristics	N (%)
Age	50 (32–64)
Sex
Female	104 (55.6)
Male	83 (44.4)
Autoimmune neurological disease	187 (100)
MG	70 (37.4)
GBS	53 (28.3)
NMOSD	35 (18.7)
CIDP	23 (12.3)
AE	6 (3.2)
Types of replacement solutions
Albumin	131
Succinylated gelatin	45
Albumin + succinylated gelatin	10
Albumin + fresh frozen plasma	1
Number of TPEs by patient	5 (5–5)

Median (IQR). MG, myasthenia gravis; GBS, Guillain–Barré syndrome; NMOSD, neuromyelitis optica spectrum disorders; CIDP, chronic inflammatory demyelinating polyneuropathy; AE, autoimmune encephalitis. TPE, therapeutic plasmatic exchange.